Metabolomics data are difficult to find and reuse, even in public repositories. We, therefore, developed the 69
ReDU addresses FAIR principles by enabling users to find and choose files (Fig 1a) . This is possible 82
because ReDU formats sample information consistently via a template and drag-and-drop validator backed by 83 standard controlled vocabularies and ontologies (e.g. NCBI taxonomy, 2 UBERON 3, Disease Ontology 4 and MS 84 ontology), and includes geographical location (important for natural products and environmental samples). ReDU 85 automatically uses all public data in the GNPS/MassIVE repository that has the corresponding ReDU-compliant 86 sample information. 34,087 files in GNPS are ReDU-compatible including natural and human-built environments, 87
human and animal tissues, biofluids, food, and other data from around the world (Fig 1f) , analyzed using different 88 instruments, ionization methods, sample preparation methods, etc. From the 103,230,404 million MS/MS spectra 89 included in ReDU, 4,528,624 spectra were annotated (rate of 4.39% with settings yielding ~1% FDR) as one of 90 13,217 unique chemicals (Table S1) . 5,6,7 91
Uniformity of data and sample information in ReDU enables metadata-based and repository-scale 92 analyses ( Fig. 1b-g) . Chemical explorer enables selection of a molecule and retrieval of its associations with the 93 metadata, i.e. sample information association. For instance, selecting 12-ketodeoxycholic acid (filtering to 94 include human feces) revealed it was observed after infancy (Fig 1c) , whereas cholic acid displayed the opposite 95 trend, coupled to the developing microbiome. Similarly, rosuvastatin was found in adults matching prescription 96 demographics. Another approach enabled is chemical enrichment analysis. For example, human blood, feces, 97 and urine differed by bilirubin, urobilin, and stercobilin (Fig 1d) . Bilirubin was more frequently annotated in blood, 98
and urobilin and stercobilin were most often annotated in feces. 8 Similarly, comparison of bacterial cultures 99 revealed differences in annotation of surfactin-C14 (observed in Bacillus subtilis) and cholic acid (observed in 00
Streptomyces). ReDU enables reanalysis based on metadata-selected files for molecular networking. 5,9,10 Re-01
analyzing human blood plasma and serum, urine, and fecal samples, networked 5,053,666 MS/MS spectra 02 (~5.6% annotated) and included annotations to clindamycin. Clindamycin's (1) molecular family matched multiple 03 datasets and sample types (Fig 1e) . Using propagation through molecular networking (e.g. delta mass and 04 MS/MS spectral interpretation), we annotated clindamycin metabolites (2-9) Fig S1-S2, Table S2-S3 . N-05 desmethylclindamycin sulfoxide (6) was observed in multiple sample types across six different datasets. At the 06 repository scale, we can map sample geographical location and identify the number of chemical annotations for 07 each sample (Fig 1f) , or locate specific molecules of interest (e.g. drugs) by mapping on the human body offline 08 (Fig 1g, Video S1) . These are representative analyses uniquely enabled by the ReDU infrastructure. 09
ReDU makes public MS/MS data FAIR and connects MassIVE (a data repository recommended by 10 Nature publishing journal for metabolomics and proteomics data) to GNPS (an analysis environment), thereby 11
integrating public data deposition, sample information curation, and data analysis. ReDU's utility will continue to 12 grow as more data is uploaded to GNPS/MassIVE,and public reference libraries expand, making ReDU a 13 resource developed by the community and FAIR for the community. data via projection onto public data visualized using EMPeror 11 . PCA was performed on GNPS annotations (level 18 2/3). 7 Human blood plasma samples (orange) from rheumatoid arthritis patients. Sample points size and color 19
were set using UBERON ontology and opacity was set using NCBI taxonomy filtering (your data, 1.0; 9606|Homo 20 sapiens, 0.7; and all other data, 0.25). (c) Metadata filters were used to select human fecal samples (NCBI 21 taxonomy, 9606|Homo sapiens; UBERON, feces) and launch sample information enrichment. Chemical explorer 22 was used to select 12-Ketodeoxycholic acid, cholic acid, and rosuvastatin. Lifestages: Infancy (<2 yrs), n=1859; 23
Early Childhood (2 yrs < x ≤ 8 yrs), n=93; Adolescence (8 yrs < 
